Thank you
This live web event has ended. Thank you for attending.
This live web event has ended. Thank you for attending.
Alex Kozhich has over 17 years of experience in the
pharmaceutical industry. For the past 8 years, Alex has worked as a Senior Principal
Scientist in the Bioanalytical Sciences Department at Bristol Myers Squibb. In this role, he provides bioanalytical
support to large molecule discovery and development projects. Previously, Alex
was an early discovery scientist at MedImmune, and also worked at a couple of
smaller diagnostic companies. He has authored over 100 papers and/or poster
presentations as primary or co-author and presented at scientific conferences
across the United States, and his research interests include bioanalytical
methods for biomolecules, peptide and protein biochemistry and immunology. Alex
received his Ph.D. in Organic Chemistry from Shemyakin Institute of Bioorganic
Chemistry and completed postdoctoral training in immunology at National
Institutes of Health.
Jad Maamary is an Associate Principal
Scientist at Merck. Jad is responsible for developing and implementing in silico and ex vivo platforms to assess the immunogenicity of various
biologics. His current work investigates the interplay
between immune modulators and cross-reactive T cell receptors that lead to
breaking of immune tolerance.
Prior to Joining Merck, Jad was a post-doctoral
fellow at Rockefeller University working in Jeffrey Ravetch’s Lab. His
Fellowship work investigated the role IgG-Fc modifications in fine tuning the
immune response to infection and vaccination. Jad Maamary obtained his PhD in
Molecular Virology under the mentorship of Peter Palese at the Mount Sinai
School of Medicine where he designed and generated novel viral vaccine vectors
and investigated their efficiency in eliciting potent immune responses.